Sentence examples for expansion incidence from inspiring English sources

Many experts hypothesize that dengue will increase in the future, including geographic expansion, incidence and reporting to WHO. 10, 23, 52, 53 It is therefore important to elaborate on some of the potential factors that drive dengue activity, as well as the global strategic direction to address this growth.

When growth factors were removed from the culture during time-lapse recording, we observed a decrease in symmetrical stem cell expansion division incidence to <70% of events.

Another important use is the impact of ART expansion on tuberculosis HIV incidence and mortality.

Expansion and increased incidence of such infections, however, are more recent, and further epidemiologic studies for tracking this phenomenon are still warranted.

Besides marked increase in cases, geographical expansion of dengue incidence from the east and southeast zones to west and north zones was also noted since 2004 (14).

The continuing expansion of high incidence areas of bovine Tuberculosis (bTB) in Great Britain (GB) raises a number of questions concerning the determinants of infection at the herd level that are driving spread of the disease.

'Intermediate recovery' (category 4) was defined as 20%to80%0% infection frequencies in all leaf axes, and no clear pattern of reduction or expansion of virus incidence in successively higher axes.

Expansion rates and the incidence rate of operative repair are more common in the 3.5-cm to 3.9-cm AAA when compared with the 3.0-cm to 3.4-cm AAA.

An emerging zoonoses is a zoonosis that is newly recognized or newly evolved, or that has occurred previously but shows an increase in incidence or expansion in geographic, host, or vector range [8].

Human factors, including both urban and rural settlement patterns, contribute to currently observed trends of increased incidence and expansion of dengue transmission.

Future approaches include large plan excellent clinical trials of oral or intravenous antioxidants, vasodilators, or novel pharmacologic agents combined with intravenous volume expansion to decrease the incidence of CI-AKI.